Clinical Trial Update: Stem Cell Transplant, Chemotherapy, and Biological Therapy in Treating Patients With High-Risk or Refractory Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on phase 1/2 testing of stem cell transplant, chemotherapy, and biological therapy in high-risk or refractory multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: University of Maryland Greenebaum Cancer Center | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 1, Phase 2 | Status: COMPLETED